A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents | MicrobiomeTrials← Back to trialsNCT04530110
A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
CompletedPHASE3INTERVENTIONAL
Trial Details
Start: 2020-09-16Est. Completion: 2025-08-15
Enrollment target: 499 participants Locations- Teva Investigational Site 14319, Aurora, Colorado, United States
- Teva Investigational Site 14368, Colorado Springs, Colorado, United States
- Teva Investigational Site 14244, Jacksonville, Florida, United States
- Teva Investigational Site 14325, Miami, Florida, United States
- Teva Investigational Site 14250, West Palm Beach, Florida, United States
- Teva Investigational Site 14255, West Palm Beach, Florida, United States
- Teva Investigational Site 14243, Atlanta, Georgia, United States
- Teva Investigational Site 14258, Savannah, Georgia, United States
- Teva Investigational Site 14263, Hoffman Estates, Illinois, United States
- Teva Investigational Site 14245, Wichita, Kansas, United States
- Teva Investigational Site 14327, Louisville, Kentucky, United States
- Teva Investigational Site 14360, Covington, Louisiana, United States
- Teva Investigational Site 14365, Baltimore, Maryland, United States
- Teva Investigational Site 14246, Waltham, Massachusetts, United States
- Teva Investigational Site 14251, Ann Arbor, Michigan, United States
Other microbiome trials you might be interested in
Preventive Treatment of Migraine
Rimegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist approved for the acute treatment of migraine …
Canoga Park, United StatesEst. completion Sep 12, 2028
Migraine
Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache,…
Huntsville, United StatesEst. completion May 2027
Teva Investigational Site 14270, Minneapolis, Minnesota, United StatesTeva Investigational Site 14376, Ridgeland, Mississippi, United StatesTeva Investigational Site 14256, Bridgeton, Missouri, United StatesTeva Investigational Site 14371, New Brunswick, New Jersey, United StatesTeva Investigational Site 14276, Amherst, New York, United StatesTeva Investigational Site 14377, Durham, North Carolina, United StatesTeva Investigational Site 14248, Raleigh, North Carolina, United StatesTeva Investigational Site 14264, Cincinnati, Ohio, United StatesTeva Investigational Site 14257, Oklahoma City, Oklahoma, United StatesTeva Investigational Site 14363, Tulsa, Oklahoma, United StatesTeva Investigational Site 14364, Philadelphia, Pennsylvania, United StatesTeva Investigational Site 14374, Bristol, Tennessee, United StatesTeva Investigational Site 14252, Austin, Texas, United StatesTeva Investigational Site 14273, Austin, Texas, United StatesTeva Investigational Site 14367, Dallas, Texas, United StatesTeva Investigational Site 14375, Salt Lake City, Utah, United StatesTeva Investigational Site 14323, Norfolk, Virginia, United StatesTeva Investigational Site 11182, Ottawa, Ontario, CanadaTeva Investigational Site 11179, Ottawa, Ontario, CanadaTeva Investigational Site 11181, Montreal, Quebec, CanadaTeva Investigational Site 40053, Helsinki, FinlandTeva Investigational Site 40049, Kuopio, FinlandTeva Investigational Site 40054, Oulu, FinlandTeva Investigational Site 40052, Tampere, FinlandTeva Investigational Site 32728, Bad Homburg, GermanyTeva Investigational Site 32729, Berlin, GermanyTeva Investigational Site 32726, Leipzig, GermanyTeva Investigational Site 80170, Be’er Ya‘aqov, IsraelTeva Investigational Site 80166, Haifa, IsraelTeva Investigational Site 80168, Holon, IsraelTeva Investigational Site 80169, Jerusalem, IsraelTeva Investigational Site 80167, Ramat Gan, IsraelTeva Investigational Site 80164, Safed, IsraelTeva Investigational Site 80165, Tel Aviv, IsraelTeva Investigational Site 30230, Florence, ItalyTeva Investigational Site 30239, Milan, ItalyTeva Investigational Site 30228, Milan, ItalyTeva Investigational Site 30226, Milan, ItalyTeva Investigational Site 30238, Padua, ItalyTeva Investigational Site 30227, Pavia, ItalyTeva Investigational Site 30225, Rome, ItalyTeva Investigational Site 38138, Doetinchem, NetherlandsTeva Investigational Site 38135, Nijmegen, NetherlandsTeva Investigational Site 38136, Rotterdam, NetherlandsTeva Investigational Site 53441, Gdansk, PolandTeva Investigational Site 53437, Kielce, PolandTeva Investigational Site 53443, Krakow, PolandTeva Investigational Site 53452, Krakow, PolandTeva Investigational Site 53440, Lublin, PolandTeva Investigational Site 53439, Poznan, PolandTeva Investigational Site 53451, Poznan, PolandTeva Investigational Site 53442, Szczecin, PolandTeva Investigational Site 31271, Barcelona, SpainTeva Investigational Site 31270, Valencia, SpainTeva Investigational Site 31265, Valladolid, SpainAVAILABLE
This is a Managed Access Program (MAP) based on a licensed physician's unsolicited request on a compassionate basis. Spe…